▮ Slide Shows

▮ Entertainment

Top Stories
Game of Thrones
▮ Music news
- Pop
- Rock
- Classic Rock
- Rap/Hip-Hop
- Country
- Alternative
- Oldies
- All Genre

▮ Content Licensing

▮ Premium NEW

▮ More

Wall Street Events

Procter & Gamble Q3 22 Earnings Conference Call At 8:30 AM ET

By RTTNews Staff Writer ✉ | Published: 4/20/2022 6:00 AM ET

Procter & Gamble Co. (PG) will host a conference call at 8:30 AM ET on April 20, 2022, to discuss Q3 22 earnings results.

To access the live webcast, log on to https://www.pginvestor.com/corporate-profile/default.aspx

For comments and feedback contact: editorial@rttnews.com

Biotech Stocks Facing FDA Decision In June 2022

Biotech Stocks Facing FDA Decision In June 2022

Biotech Stocks Facing FDA Decision In March 2022

Biotech Stocks Facing FDA Decision In March 2022

Biotech Stocks Facing FDA Decision In February 2022 non small cell lung cancer chemotherapy

Biotech Stocks Facing FDA Decision In February 2022

Latest Updates on COVID-19

193K New Covid Cases, 710 Deaths In U.S.

18K New Covid Cases, 144 Deaths In US

Pfizer Signs $3.2 Bln COVID Vaccine Deal With US Government

125K New Covid Cases, 549 Deaths In U.S.

FDA Experts Recommend Updated Booster Shots To Fight Contagious Omicron Variant In Fall

Read More

COVID-19: Drugs in Development

RELATED NEWS

Procter & Gamble To Present At Goldman Sachs Global Staples Forum; Webcast At 10:20 AM ET

P&G Q3 Results Top View; Backs FY22 Core EPS Outlook

Procter & Gamble Co. Bottom Line Advances In Q3, Beats estimates

Procter & Gamble Q3 22 Earnings Conference Call At 8:30 AM ET

P&G Names Jon Moeller As Chairman To Succeed David Taylor

Follow RTT

Editor's Pick
Most Read
Most Emailed

FCC Authorizes SpaceX To Use Starlink Internet Service On Vehicles In Motion

Loud Muscle Science Recalls Launch Sequence Products

US To Import 17 Mln Bottles Of Infant Formula From New Zealand, Ireland

Children's Sleepwear Sold At Amazon Recalled

Pfizer Signs $3.2 Bln COVID Vaccine Deal With US Government

Samsung Starts Mass Production Of Most Advanced 3-nm Chips

Morphine Sulfate Extended-Release Tablets Recalled Due To Label-Mix Up

FTC Sues Walmart For Facilitating Money Transfer Fraud

Bed Bath & Beyond Q1 Results Miss Estimates

Tesla Cuts 200 Autopilot Jobs, Closes San Mateo Office

FDA Experts Recommend Updated Booster Shots To Fight Contagious Omicron Variant In Fall

Creminelli Recalls Mini Parmesan Salami Stick Products

FCC Authorizes SpaceX To Use Starlink Internet Service On Vehicles In Motion

TD SYNNEX Q2 Results Top Estimates; Reaffirms FY22 Adj. EPS Outlook

Walmart To Buy Memomi For Undisclosed Sum

General Mills Gains On Upbeat Q4 Results, Increased Dividend

Novavax's Prototype Vaccine Shows Broad Immune Responses Incl. Against Omicron And Other Variants

Micron Technology Q3 Profit Increases, beats estimates

FDA Proposes Rule To Advance Consumer Access To OTC Drugs

Kezar Life Sciences Stock Surges 105% On Positive Data Drug Trial Results

Teva Pharmaceutical Appoints Eric Hughes As Chief Medical Officer

Missfresh Finds 'Questionable Transactions' In Internal Review

Siemens Expects Non-cash Impairment Of EUR 2.8 Bln On Its Investment In Siemens Energy

Alaunos Extends Cooperative Research And Development Agreement With NCI

WPP To Buy Bower House Digital For Undisclosed Sum

Gilead: Kite's CAR T-cell Therapy Yescarta Gets EU Approval To Treat Relapsed Or Refractory FL

FCC Authorizes SpaceX To Use Starlink Internet Service On Vehicles In Motion

GSK: Japan Accepts Regulatory Submission For Shingrix To Prevent Shingles In At Risk 18+

Frasers Group Acquires Stake In Australian-based MySale Plc

AlerisLife Confirms CFO Jeff Leer As President And CEO

Beyond Air's LungFit PH Gets FDA Approval, Stock Jumps 25%

General Mills Initiates FY23 Outlook; Boosts Qtly Dividend 6% - Update

Samsung Starts Mass Production Of Most Advanced 3-nm Chips

Pfizer And BioNTech Reach New Agreement With U.S. To Provide Addl Doses Of COVID-19 Vaccine

Blueprint Medicines Enters Financing Collaborations With Sixth Street And Royalty Pharma

Morphine Sulfate Extended-Release Tablets Recalled Due To Label-Mix Up